SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-125361
Filing Date
2024-11-12
Accepted
2024-11-12 16:08:06
Documents
14
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20241112.htm   iXBRL 8-K 43796
2 EX-99.1 crnx-ex99_1.htm EX-99.1 124874
3 GRAPHIC img113038668_0.jpg GRAPHIC 6091
4 GRAPHIC img113038668_1.jpg GRAPHIC 6091
  Complete submission text file 0000950170-24-125361.txt   307412

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20241112.xsd EX-101.SCH 23893
16 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20241112_htm.xml XML 4534
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 241448089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)